Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and hybrid capture 2 tests for detection of high-grade lesions of the uterine cervix

Journal of Clinical Microbiology

Volumn 50, Issue 4, 2012, Pages 1240-1244

  Lapierre, Simon Grandjean ^a   Sauthier, Philippe ^a,b   Mayrand, Marie Hélène ^a,b   Dufresne, Simon ^a   Petignat, Patrick ^c   Provencher, Diane ^a,b   Drouin, Pierre ^a,b   Gauthier, Philippe ^a,b   Dupuis, Marie Josée ^a,b   Michon, Bertrand ^a,b   Ouellet, Stéphan ^a,b   Hadjeres, Rachid ^a,b   Ferenczy, Alex ^d   Franco, Eduardo L ^e   Coutlée, François ^a,b,e  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL SQUAMOUS CELL; COLPOSCOPY; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INTERMETHOD COMPARISON; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; DNA, VIRAL; EPITHELIUM; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 84858606730     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06656-11     Document Type: Article

References (22)

1. Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. 2005. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol. Oncol. 99:S7-S11. (Pubitemid 41774340)
2. Atypical Squamous Cells of Undetermined Significance/Low Grade Squamous Lesions Triage Study Group. 2003. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am. J. Obstet. Gynecol. 188:1383-1392.
3. Bouvard V, et al. 2009. A review of human carcinogens. Part B: biological agents. Lancet Oncol. 10:321-322.
4. Castle PE, et al. 2009. Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J. Clin. Microbiol. 47:3344-3347.
5. Castle PE, Solomon D, Schiffman M, Wheeler CM. 2005. Human papillomavirus type 16 infections and 2-year absolute risk of cervical pre-cancer in women with equivocal or mild cytologic abnormalities. J. Natl. Cancer Inst. 97:1066-1071. (Pubitemid 41417923)
6. Castle PE, et al. 2011. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol. 12:880-890.
7. Coutlee F, Mayrand MH, Roger M, Franco EL. 2009. Detection and typing of human papillomavirus nucleic acids in biological fluids. Public Health Genomics 12:308-318.
8. Coutlee F, et al. 2007. Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J. Clin. Microbiol. 45:3821-3823. (Pubitemid 350156895)
9. Coutlee F, et al. 2006. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J. Clin. Microbiol. 44:1998-2006. (Pubitemid 43902145)
10. Dufresne S, et al. 2011. HPV DNA triage of women with ASCUS living in Montreal: demonstration of differences between Amplicor HPV and Hybrid Capture 2. J. Clin. Microbiol. 49:48-53.
11. Franco EL, Harper DM. 2005. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 23:2388-2394. (Pubitemid 40341489)
12. Heideman DA, et al. 2011. Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J. Clin. Microbiol. 49:3983-3985.
13. Kim JJ, Wright TC, Goldie SJ. 2002. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 287:2382-2390. (Pubitemid 34493201)
14. Lindemann ML, et al. 2012. Analytical Comparison of the cobas HPV Test with Hybrid Capture 2 for the Detection of High-Risk HPV Genotypes. J. Mol. Diagn. 14:65-70.
15. Mateos ML, Chacon de Antonio J, Rodriguez-Dominguez M, Sanz I, Rubio MD. 2011. Evaluacion de un sistema de PCR a tiempo real (cobas 4800) para la deteccion separada de los genotipos 16 y 18 y otros genotipos de alto riesgo del virus del papiloma humano en la prevencion del cancer cervical. Enferm. Infecc. Microbiol. Clin. 29:411-414.
16. Meijer CJ, et al. 2009. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int. J. Cancer 124:516-520.
17. Schiffman M, et al. 2011. Human papillomavirus testing in the prevention of cervical cancer. J. Natl. Cancer Inst. 103:368-383.
18. Solomon D, Schiffman M, Tarone R, ALTS Study Group. 2001. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J. Natl. Cancer Inst. 93:293-299. (Pubitemid 32219816)
19. Stoler MH, et al. 2011. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am. J. Clin. Pathol. 135:468-475.
20. Trottier H, Franco EL. 2006. The epidemiology of genital human papillomavirus infection. Vaccine 24:S1-S15.
21. Wright TCJ, et al. 2007. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am. J. Obstet. Gynecol. 197:346-355.
22. Wright TCJ, et al. 2011. Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results. Am. J. Clin. Pathol. 136:578-586.